Global High-Priority Regulatory Events — March 27, 2026

27-03-2026

Infrastructure Leasing & Financial Services Limited (IL&FS) has intimated BSE Limited under Regulation 51 of LODR that it is unable to service the interest payment on its Non-Convertible Debentures (NCD Series 2017-I-Q, ISIN: INE871D07RJ2) due on March 27, 2026. This event signals a debt servicing default with potential implications for creditors and liquidity.

• ·ISIN No.: INE871D07RJ2
• ·Registered Office: The IL&FS Financial Center, Plot C-22, G Block, Bandra-Kurla Complex, Bandra East, Mumbai 400 051
• ·CIN No.: L65990MH1987PLC044571

27-03-2026

VivoSim Labs, Inc., a Delaware-incorporated life sciences company formerly known as Organovo Holdings, Inc., filed an S-1 registration statement on March 27, 2026, for a best-efforts offering of common stock and warrants priced at $1.69 per share (last reported Nasdaq sale price on March 26, 2026), with no minimum proceeds required. The company reported net losses of $2.7 million for the three months ended December 31, 2025, and an accumulated deficit of $350.2 million through that date, with cash on hand insufficient beyond July 2026 and auditor's going concern doubt for FY ended March 31, 2025. Potential $3.4 million net proceeds could extend runway into 2027, but risks include substantial dilution of $0.36 per share, cashless warrant exercises causing further dilution, and difficulty raising additional $5.0 million needed through end of 2027.

• ·Fiscal year end: March 31
• ·Current cash runway: beyond July 2026 without offering proceeds
• ·Auditor's report for FY ended March 31, 2025 includes going concern explanatory language
• ·Best-efforts offering with no minimum amount or escrow; proceeds immediately available
• ·Common warrants exercisable for 5 years at $[blank] per share; cashless exercise likely
• ·Business address: 11555 Sorrento Valley Road, Suite 100, San Diego, CA 92121; Phone: 858-224-1000

27-03-2026

Excel Industries Limited has informed BSE and NSE that the trading window for dealing in its equity shares by designated persons and their immediate relatives will remain closed from April 1, 2026, until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026, in compliance with the Company's Code of Conduct for Prevention of Insider Trading and SEBI regulations. The trading window remains open for general investors. This is a standard pre-earnings blackout period with no other financial or operational impacts disclosed.

• ·Company certifications: ISI/ISO9001:2015, ISI/ISO14001:2015, ISI/ISO 45001:2018 by BIS.
• ·BSE Scrip Code: 500650; NSE Scrip Code: EXCELINDUS.
• ·CIN: L24200MH1960PLC011807.

27-03-2026

SLM Student Loan Trust 2011-3's 10-K annual report for the fiscal year ended December 31, 2025, confirms full compliance with applicable servicing criteria by Navient Solutions, LLC (Servicer and Administrator), Higher Education Loan Authority of the State of Missouri (Subservicer), and Deutsche Bank National Trust Company (Indenture Trustee), with no material instances of noncompliance reported. The filing discloses ongoing legal proceedings involving Navient Corporation and Deutsche Bank entities as trustees in RMBS litigations (e.g., NCUA, Commerzbank, IKB cases), but all parties assert these do not materially impact their duties under the Indenture for this trust. No single obligor exceeds 10% of pool assets, and there are no external credit enhancements or derivative instruments.

• ·No entity or group provides external credit enhancement or derivative instruments for notes.
• ·Servicing Reports and Attestation Reports for all Servicing Parties attached as exhibits with no material noncompliance.
• ·Legal proceedings against Navient and Deutsche Bank entities ongoing but not material to noteholders or trust performance.
• ·Trust formation documents dated November 18, 2011.

27-03-2026

Fuel Tech, Inc. announced its 2026 Corporate Incentive Plan (CIP), effective January 1, 2026, which provides annual cash bonuses to eligible U.S., European, and Canadian employees based on company Operating Income and individual performance, superseding prior bonus programs. No payouts occur unless Operating Income reaches a $250,000 threshold, with the incentive pool funded at 25% of Operating Income thereafter, capped at $3 million. Payouts are calculated using a formula incorporating base wages, target bonus factors, and realization percentages, with executives automatically at 100%.

• ·Eligible Employees exclude Sales Group members and those with separate ineligibility agreements; must be employed on December 31, 2026, for full payout eligibility (pro-rata for involuntary termination not for cause, death, or Disability).
• ·Individual Objectives communicated by April 15, 2026; Target Bonus Factors also by April 15, 2026.
• ·Plan administered by Compensation Committee with full discretion to amend or cancel at any time.
• ·Operating Income defined before impact of incentive pay but including sales commissions.

27-03-2026

ZOOZ Strategy Ltd.'s 20-F Annual Report filed March 27, 2026, details extensive risk factors, prominently featuring vulnerabilities from its bitcoin treasury strategy such as price volatility, regulatory uncertainties including potential reclassification as a security or investment company under the 1940 Act, and IT/security breaches. Other key risks include Nasdaq delisting risk if closing bid price falls below $1.00 per share, customer concentration exposing it to credit losses, geopolitical tensions in Israel/Middle East, PFIC tax status for U.S. investors, dilution from warrants/RSUs/options and earnout rights totaling up to 4,000,000 ordinary shares, and challenges in financing growth, IP protection, and talent retention. No financial performance metrics are provided, emphasizing potential adverse impacts on operations, share price, and capital access.

• ·Earnout milestones based on VWAP over any 20 Trading Days within a 30 Trading Day period during the Earnout Period, subject to adjustments for share splits, dividends, etc.
• ·Risk of classification as PFIC for U.S. federal income tax purposes, leading to adverse tax consequences for U.S. investors.
• ·Potential loss of foreign private issuer status, increasing compliance costs.
• ·Customer concentration risks including negotiation leverage, order delays/cancellations, and credit losses on receivables.

27-03-2026

AnaptysBio's Board of Directors approved the spin-off of First Tracks Biotherapeutics, Inc., with a distribution date of April 20, 2026 (record date April 6, 2026), providing Anaptys stockholders one share of First Tracks Bio (ticker: TRAX) common stock per Anaptys (ANAB) share held. First Tracks Bio will launch as a clinical-stage biotech with $180 million initial cash ($100 million from Anaptys, $80 million from private placement), a two-year cash runway, and a pipeline including ANB033 (Phase 1b), rosnilimab (Phase 2b completed), and ANB101 (Phase 1a). Daniel Faga will serve as CEO of both companies post-spin-off, with additional leadership including Paul Lizzul (CMO), Ben Stone (CBO), and incoming CFO Ajim Tamboli.

• ·Spin-off distribution expected April 20, 2026, pre-market; record date April 6, 2026.
• ·When-issued trading for TRAX begins on or about April 6, 2026; regular-way trading April 20, 2026.
• ·U.S. federal income tax purposes: distribution expected to be taxable for Anaptys.
• ·No action required by Anaptys stockholders; no payment or share surrender needed.
• ·Ajim Tamboli (>25 years experience) starts as CFO on April 20, 2026.
• ·Investor contact: Nick Montemarano, 858.732.0178, investors@anaptysbio.com

27-03-2026

Shizuoka Financial Group, Inc. (Shizuoka FG) and The Bank of Nagoya, Ltd. entered into a Memorandum of Understanding (MOU) on March 27, 2026, to proceed with discussions toward a business integration via share exchange, targeting an effective date of April 1, 2028, under which Shizuoka FG will become the wholly-owning parent and The Bank of Nagoya a wholly-owned subsidiary, leading to delisting of Nagoya's shares. The integration aims to achieve synergies through broader-area collaboration, improved efficiency via shared resources, and enhanced capital efficiency (ROE), building on their existing 'Shizuoka Nagoya Alliance' since April 2022. As of December 31, 2025, Shizuoka FG reports consolidated total assets of ¥15,878,358 million and deposits of ¥12,101,303 million, while The Bank of Nagoya has ¥6,235,491 million and ¥5,384,984 million, respectively.

• ·Integration preparation committee to be co-chaired by Presidents Shibata and Fujiwara.
• ·Share exchange ratio to be determined post due diligence and third-party valuation.
• ·Definitive agreement scheduled for March 2027; Nagoya shareholder meeting December 2027.
• ·Shizuoka FG plans simplified share exchange without shareholder approval, subject to confirmation.

27-03-2026

Marriott International, Inc. has issued its 2026 Proxy Statement for the virtual Annual Meeting on May 8, 2026, at 8:30 a.m. ET, where shareholders of record as of March 11, 2026, will vote on electing 12 director nominees (Board recommends FOR each), ratifying Ernst & Young LLP as independent auditors for fiscal year 2026 (FOR), and an advisory vote to approve executive compensation (FOR). As of the record date, 264,931,993 shares of Class A common stock were outstanding, each entitled to 10 votes. No financial performance metrics or period-over-period comparisons are discussed in this procedural filing.

• ·Annual Meeting access: www.virtualshareholdermeeting.com/MAR2026; requires control number.
• ·Voting methods: Internet (www.proxyvote.com), phone, mail, or online during meeting; deadline May 7, 2026, 11:59 p.m. ET for phone/Internet.
• ·Retirement Plan voting instructions due by May 5, 2026, 11:59 p.m. ET.
• ·Director election: majority of votes cast (FOR > AGAINST); abstentions and broker non-votes have no effect.
• ·Ratification and say-on-pay: majority of shares present and entitled to vote; abstentions count as AGAINST.

27-03-2026

Enterprise Products Operating LLC, a subsidiary of Enterprise Products Partners L.P., entered into a $1,500,000,000 364-Day Revolving Credit Agreement on March 27, 2026, with Citibank, N.A. as Administrative Agent and a syndicate of lenders including Wells Fargo Bank, JPMorgan Chase Bank, Mizuho Bank, MUFG Bank, Truist Bank, Barclays Bank PLC, Royal Bank of Canada, Sumitomo Mitsui Banking Corporation, The Bank of Nova Scotia, and The Toronto-Dominion Bank as key agents. The facility provides short-term revolving credit commitments, with interest rates tied to ratings-based spreads (SOFR Spread 0.710%-1.125%, ABR Spread 0%-0.125%, Facility Fee 0.040%-0.125%). No prior period comparisons or performance metrics are disclosed.

• ·Facility matures 364 days from Effective Date.
• ·Applicable Rate categories based on Index Debt ratings from Moody’s/S&P (Category 1: A1/A+ SOFR Spread 0.710%, Facility Fee 0.040%; Category 5: <Baa2/BBB SOFR Spread 1.125%, Facility Fee 0.125%).
• ·Availability Period: from Effective Date to earlier of Maturity Date or Commitments termination.

27-03-2026

Alamar Biosciences, Inc. filed an S-1 registration statement on March 27, 2026, for an initial public offering on Nasdaq under the symbol 'ALMR', with financials showing strong revenue growth from $25.1M in 2024 to $74.2M in 2025 (195% YoY), driven by product revenue surging 249% to $58.4M and gross profit expanding 385% to $41.7M. However, operating expenses increased 26% to $73.0M, largely from SG&A doubling to $35.6M while R&D dipped slightly by 4% to $37.5M, resulting in a reduced net loss of $29.8M from $47.1M YoY but ongoing unprofitability. The company held $30.0M in cash as of December 31, 2025, with $56.5M convertible notes issued in January 2026.

• ·Stock-based compensation expense increased to $2.9M in 2025 from $0.9M in 2024.
• ·Total assets $140.0M and stockholders' deficit $(158.9M) as of Dec 31, 2025.
• ·Net loss per share, basic, improved to $(1.07) in 2025 from $(1.82) in 2024.
• ·Weighted-average exercise price for 2018 Plan options: $1.32 per share as of Dec 31, 2025.
• ·Weighted-average exercise price for warrants: $1.47 per share as of Dec 31, 2025.
• ·Series C Warrant exercise price: $2.9775 per share.
• ·Phantom Plan weighted-average exercise price: $1.79 per share.

27-03-2026

J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has issued a notice for an equity shareholders' meeting on April 28, 2026, at 2:00 p.m. IST via VC/OAVM, to consider and approve the Scheme of Amalgamation with Torrent Pharmaceuticals Limited, pursuant to the National Company Law Tribunal, Ahmedabad Bench order dated March 23, 2026. Remote e-voting opens April 24, 2026, at 9:00 a.m. IST and ends April 27, 2026, at 5:00 p.m. IST, with a cut-off date of April 21, 2026. The notice includes annexures such as financial statements for the quarter and nine months ended December 31, 2025, valuation reports, fairness opinions, and board reports.

• ·Tribunal Order dated March 23, 2026 in Company Application No. CA(CAA)/6(AHM)2026.
• ·Annexures include unaudited standalone and consolidated financials for quarter and nine months ended December 31, 2025 for both companies.
• ·Joint Share Exchange Ratio Report dated June 29, 2025 by Ernst & Young and BDO.
• ·Fairness Opinions dated June 29, 2025 by Axis Capital and ICICI Securities.
• ·BSE and NSE observation letters dated February 17, 2026.
• ·CIN of JB Pharma: L24390GJ1976PLC173077.
• ·BSE Scrip Code: 506943, Stock Symbol: JBCHEPHARM.

27-03-2026

Horace Mann Educators Corporation announced that Maureen Temchuk, Vice President, Controller and Chief Accounting Officer, will commence temporary maternity leave on or about March 30, 2026, expected to last until approximately July 6, 2026. Ryan Greenier, Executive Vice President and Chief Financial Officer, will serve as Interim Chief Accounting Officer during her absence, with no changes to his current compensation. The company expects Temchuk to resume her role upon completion of her leave.

• ·Ryan Greenier, age 44, has served as Executive Vice President and Chief Financial Officer since 2024; previously held roles including Deputy CFO, Chief Investment Officer, and others at Horace Mann.
• ·Prior to Horace Mann, Ryan Greenier held leadership roles at The Hartford and began his career at Deloitte and Touche; holds BBA in Accounting from Pace University and MBA in Finance from University of Connecticut.
• ·There are no arrangements or understandings with Ryan Greenier regarding his interim role, and no related-party transactions under Item 404(a) of Regulation S-K.

27-03-2026

Virat Industries Ltd. received listing approval from BSE Ltd. on March 27, 2026, for 95,99,999 equity shares of Rs.10 each allotted on a preferential basis to Mr. Bhavook Chandraprakash Tripathi. This intimation is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No declines or flat metrics are applicable as this pertains to a corporate action without comparative financial data.

• ·Scrip Code: 530521
• ·CIN: L29199GJ1990PLC014514

27-03-2026

27-03-2026

Origin Materials reported Q4 2025 revenue of $3.0 million, down 67% YoY from $9.2 million, and full-year 2025 revenue of $18.9 million, down 40% from $31.3 million in 2024, due to the planned wind-down of its supply chain activation program. Operating expenses surged to $194.7 million in Q4 (up over 1,100% YoY) and $259.6 million for the full year (up 204% YoY), driven by a $178.8 million non-cash impairment on furanics assets, resulting in Q4 net loss of $194.1 million and full-year net loss of $249.7 million; however, Adjusted EBITDA loss narrowed slightly to $10.8 million in Q4 (from $10.5 million) and $43.4 million for the year (from $48.4 million). Cash and equivalents stood at $53.5 million, sufficient into Q3 2026, with progress on PET caps delivery to ~30 prospects and distribution deals, though breakeven now delayed to 2028 from 2027.

• ·Convertible debt facility: $15M initial tranche drawn, option for up to $90M total, but limited use due to stock price decline.
• ·Non-binding $20M equipment financing term sheet did not progress due to lender valuation changes.
• ·CapFormer production: six lines fully procured, projected installation by end of 2026.
• ·First Origin PET caps on store shelves in California in August 2025.

27-03-2026

BiomX Inc. received a notice from NYSE American on March 25, 2026, stating non-compliance with continued listing standards under Sections 1003(a)(i), (ii), and (iii) of the Company Guide due to stockholders' equity below required thresholds of $2.0 million, $4.0 million, and $6.0 million, respectively, given reported losses from continuing operations and/or net losses in two of three, three of four, and five most recent fiscal years. The company is ineligible for exemptions, including those for market capitalization over $50 million, and must submit a compliance plan by April 24, 2026, to achieve compliance by September 25, 2027, or face delisting proceedings. The notice has no immediate impact on trading of PHGE common stock, but the FY2025 auditor's report includes a going concern qualification.

• ·Company must submit compliance plan by April 24, 2026.
• ·If plan accepted, compliance required by September 25, 2027, with quarterly monitoring.
• ·Going concern qualification in auditor’s report for Form 10-K filed February 19, 2026, for fiscal year ended December 31, 2025.
• ·Common stock, $0.0001 par value, trades on NYSE American under symbol PHGE with no immediate trading impact.

27-03-2026

Forum Markets, Incorporated (formerly ETHZilla Corp, ticker FRMM), through its subsidiary ETHZilla Modular Mortgage LLC, entered into a Master Loan Purchase Agreement and Master Loan Servicing Agreement with Zippy Loans, LLC, committing to purchase up to $150,000,000 in manufactured home chattel loans over a five-year term on a revolving basis. The first Purchase Commitment covers up to $15,000,000 through June 30, 2026, with an initial acquisition of 31 loans for $1,436,710.67 funded by cash on hand. The company holds approximately 15% ownership in Zippy, Inc., the parent of Zippy Loans.

• ·Loans must meet eligibility criteria including FICO score, loan-to-value ratio, loan size, loan term, and geographic concentration.
• ·Acquisition of Initial Loans determined to be assets, not a business; no financial statements or pro forma information required under Item 9.01.
• ·Zippy Loans to service purchased Loans with tiered servicing fee based on FICO score and minimum monthly fee.
• ·MLPA and MLSA effective March 23, 2026; filed as Exhibits 10.1, 10.2, and 10.3.

27-03-2026

CareCloud, Inc. disclosed a material cybersecurity incident on March 16, 2026, involving a temporary network disruption in its CareCloud Health division that affected 1 of 6 electronic health record environments for approximately 8 hours, which was fully restored the same day with no ongoing access by the threat actor. The incident was contained, reported to authorities and cybersecurity insurance carrier, and is not believed to have materially impacted operations to date; however, an ongoing investigation assesses potential data access or exfiltration of patient information, with possible remediation costs, legal, regulatory, and reputational risks. The company has engaged external experts for forensics and remediation but has not finalized the full scope or impact.

• ·Incident reported to cybersecurity carrier and law enforcement authorities.
• ·Engaged leading cyber response advisory team from a Big Four accounting firm for investigation and remediation.
• ·Filing determined incident material on March 24, 2026, despite no current material operational impact.

27-03-2026

Delek Logistics Partners, LP entered into a new Credit Agreement dated March 26, 2026, with Truist Bank as Administrative Agent, various lenders including Bank of America, N.A., Citizens Bank, N.A., The Huntington National Bank, Mizuho Bank, Ltd., MUFG Bank, Ltd., and Wells Fargo Bank, N.A. as Co-Syndication Agents, and Barclays Bank PLC, KeyBanc Capital Markets Inc., and Regions Bank as Co-Documentation Agents. The agreement refinances the prior Fourth Amended and Restated Credit Agreement dated October 13, 2022, with Fifth Third Bank as prior agent, and supports revolving loans, letters of credit, swing loans for working capital, investments, capital expenditures, restricted payments, and general corporate purposes. No specific facility size or terms changes indicate improvements or declines.

• ·SEC 8-K filing dated March 27, 2026, covering Items 1.01, 1.02, 2.03, 9.01
• ·Effective Date Refinancing of prior indebtedness under October 13, 2022 agreement
• ·Includes collateral, guaranties, financial covenants, and standard events of default

27-03-2026

Hoth Therapeutics, Inc. filed its 10-K annual report on March 27, 2026, disclosing no revenue from commercial sales, uncertain future profitability, and heavy dependence on the clinical success of licensed products and technologies. The filing emphasizes substantial risks including potential delays and costs in clinical studies, failure to obtain regulatory approvals, and compliance challenges with laws like HIPAA, FDCA, Sunshine Act, and FCPA, which could limit revenue generation and lead to total investment loss if capital is not secured. Consolidated financial statements compare the years ended December 31, 2025 and 2024, but no specific performance improvements are noted amid these ongoing operational uncertainties.

• ·Financial statements include Consolidated Balance Sheets as of December 2025 and 2024 (F-4), Statements of Operations and Comprehensive Loss for years ended December 31, 2025 and 2024 (F-5), Statements of Changes in Stockholders’ Equity (F-6), and Statements of Cash Flows (F-7).
• ·Report of Independent Registered Public Accounting Firm (PCAOB ID: 100) on F-2.
• ·Risks include potential repayment of amounts received in violation of law, mandated changes to practices increasing expenses, corporate integrity agreements, and termination of business relationships.

27-03-2026

Blackstone Real Estate Income Trust, Inc. (BREIT)'s 2026 proxy statement details its corporate governance framework, including the Code of Business Conduct and Ethics, Corporate Governance Guidelines, stockholder nomination policies, and insider trading policy, with a majority independent board and a dedicated Affiliate Transaction Committee. It emphasizes Blackstone's sustainability integration, human capital development (e.g., BX Curriculum, Conscious Inclusion training with 64% workforce participation), and community engagement via programs like Blackstone Connects (87% employee participation) and BX Impact (100% U.S. portfolio company engagement in 2025). No material declines or flat metrics are reported.

• ·Insider trading policy filed with 10-K for year ended December 31, 2024.
• ·Stockholder proposals for 2027 Annual Meeting subject to bylaws' advance notice requirements.
• ·BREIT produced a 2025 Sustainability Report with TCFD-aligned disclosures.
• ·Blackstone is a signatory to Principles for Responsible Investment (PRI) and member of Business for Social Responsibility (BSR) and ILPA Diversity in Action Initiative.

27-03-2026

On March 23, 2026, Michael Salvator resigned as Director (including from Compensation and Audit Committees) and Jonathan Darnell resigned as Chief Financial Officer, both effective immediately and without any disagreements with the Board on operations, policies, or practices. On March 26, 2026, the Board elected Andrew Schoff as Director (to serve on Compensation and Audit Committees) and appointed Andrea Dobi as Chief Financial Officer, both effective immediately. No family relationships, arrangements, or related-party transactions under Item 404(a) of Regulation S-K were disclosed for the new appointees.

• ·Andrew Schoff, age 44, Founder and CIO of S3 Management LLC; previously Founding Partner at Tide Point Capital, Senior Analyst at Harbor Watch Capital and Diamondback Capital, Associate at Prudential Equity Group; B.A. in Economics from Hamilton College.
• ·Andrea Dobi, age 52, COO of AltEnergy, LLC since September 2009; previously at J.H. Whitney & Co.; graduated from Fairfield University.
• ·Company is an emerging growth company.
• ·Securities trade on OTC Pink Open Market: AEAEU (Units), AEAE (Class A common stock), AEAEW (Warrants).

27-03-2026

Two Harbors Investment Corp. (TWO) announced a definitive merger agreement to be acquired by an affiliate of CrossCountry Mortgage (CCM) for $10.80 per share in cash, terminating its prior merger agreement with UWM Holdings Corporation dated December 17, 2025, and agreeing to pay a $25.4 million termination fee to UWM. The transaction, unanimously approved by TWO's board and recommended for stockholder approval, is expected to close in the second half of 2026, subject to customary conditions including regulatory approvals, with no financing condition. Holders of TWO's preferred stock will be redeemed at $25.00 per share plus accumulated dividends, while TWO plans to continue regular quarterly dividends prior to closing but no partial dividend in the closing quarter.

• ·TWO's prior stockholder meeting scheduled for April 7, 2026, to approve UWM merger has been canceled.
• ·Transaction not subject to financing condition; TWO common stock to be delisted from NYSE upon closing.
• ·Advisors: Houlihan Lokey (financial) and Jones Day (legal) for TWO; Citigroup (financial) and Simpson Thacher & Bartlett (legal) for CCM.

27-03-2026

Bayer CropScience Limited received an order on March 26, 2026, from the Office of the Assistant Commissioner, Central GST, Division-IV (Narol), Ahmedabad, Gujarat, imposing a penalty of Rs. 11.87 Million related to GST on Outward Supply for FY 2019-20. The company states the order is appealable and plans to assess exercising its right to appeal. No positive financial developments or offsets are mentioned.

• ·Disclosure made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015
• ·Order details enclosed as Annexure I in filing dated March 27, 2026

27-03-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) announced the appointment of five new independent directors effective March 31, 2026—Alex Cruz, Kevin A. Lansberry, Steve Pagliuca, Brian P. MacDonald, and Jonathan Z. Cohen—following a cooperation agreement with Elliott Investment Management L.P. to enhance board refreshment and shareholder value. Four directors—Stella David, David M. Abrams, Harry C. Curtis, and Mary E. Landry—will resign, resulting in a nine-member board with eight independents; John W. Chidsey is appointed Chairman and Alex Cruz as Lead Independent Director. The changes aim to improve execution amid strategic growth, with NCLH's fleet at 35 ships and nearly 75,000 Berths, planning 16 more ships adding over 43,000 Berths by 2037.

• ·Company slate for 2026 Annual General Meeting: Zillah Byng-Thorne, Linda P. Jojo, Alex Cruz.
• ·Elliott agreed to customary standstill and voting commitments in cooperation agreement.
• ·Advisors: Goldman Sachs & Co. LLC (financial), Paul Hastings LLP (legal), Joele Frank, Wilkinson Brimmer Katcher (strategic communications).

27-03-2026

Onix Renewable (Acquirer) along with PACs Divyesh Mansukhbhai Savaliya (PAC1), Piyush Mansukhbhai Savaliya (PAC2), and Nikhil Hareshbhai Savaliya (PAC3) are making a mandatory open offer to acquire up to 17,30,400 equity shares (19.28% of emerging voting share capital) of Sarda Proteins Ltd at Rs. 115 per share, for a maximum consideration of Rs. 19,89,96,000. Target company's total revenue declined to 57,626.88 Lakhs as of 30.09.2025 from 97,595.59 Lakhs as of 31.03.2025, while net income fell to 4,794.59 Lakhs from 10,522.54 Lakhs; however, net worth increased to 77,863.23 Lakhs from 69,337.79 Lakhs. The offer size is restricted to shares held by eligible public shareholders per Regulation 7(6) of SEBI (SAST) Regulations.

• ·Paid-up equity share capital discrepancy: BSE records show 1,72,59,000 vs MCA 2,50,45,000 due to unreflected share forfeitures.
• ·Emerging voting share capital post warrant conversion: 89,75,900 equity shares.
• ·Public announcement dated March 18, 2026; no statutory approvals required as of DPS date.
• ·Offer not conditional on minimum acceptance; no delisting proposed.
• ·Acquirer/PACs from Onix Group; no SEBI prohibitions or wilful defaulter status.

27-03-2026

Indian Railway Finance Corporation Ltd (IRFC) disclosed notices from NSE and BSE dated February 27, 2026, for non-compliance with SEBI LODR Regulations 17(1), 18(1), and 19(1)/19(2) regarding board composition and audit/nomination committees for the quarter ended December 31, 2025, resulting in fines of ₹828,000 plus 18% GST of ₹149,040 (total ₹977,040). The Board, in its meeting on March 9, 2026, noted the fines, requested waivers citing prior precedents (March-December 2021) and the company's status as a government entity where director appointments are controlled by the Ministry of Railways, and urged expedited appointment of Independent Directors including a woman director. No compliance has been achieved yet, with fines accruing daily until rectification.

• ·Non-compliance pertains to lacking requisite Independent Directors (including one Woman Independent Director) on the Board.
• ·Appointments vested with President of India via Ministry of Railways; company has no control.
• ·Prior fines waived by exchanges for similar non-compliances from March 2021 to December 2021.
• ·Fines continue accruing daily until compliance; waiver requires prior compliance and ₹10,000 + GST processing fee.

27-03-2026

Equifax's 2026 Proxy Statement details 2025 record revenue of $6.075 billion, up 7% YoY from 2024, and adjusted EPS of $7.65, up 5% YoY, resulting in AIP payouts of 152.1% of target for CEO Mark W. Begor and 154.5% average for other NEOs amid U.S. mortgage and hiring market weakness. However, AIP payouts were below target in 2022-2024 due to unprecedented U.S. mortgage declines and macroeconomic challenges, with 2022-2024 LTI cycles (TSR and Adjusted EBITDA performance shares) also paying out below target. The filing nominates 10 directors for election, highlights board refreshment with 9/10 independent nominees, and outlines governance practices including separate CEO/Chairman roles and shareholder engagement with 55% of shares.

• ·Shareholder outreach post-2025 Annual Meeting engaged investors holding 55% of outstanding shares, discussing compensation, governance, AI oversight, and consumer initiatives.
• ·Compensation Committee approved 2025 CEO arrangement with enhanced retentive elements and increased target LTI opportunity; 2026 changes include 5-year LTI horizon and flat CEO pay.
• ·Governance highlights: Director stock ownership 5x retainer (independents), 6x/3x base salary (CEO/other execs); limits on outside boards; no poison pill; proposal to lower special meeting threshold to 25%.
• ·Operates or invests in 24 countries across North America, Central/South America, Europe, Asia Pacific.

27-03-2026

Shirpur Gold Refinery Ltd, undergoing Corporate Insolvency Resolution Process (CIRP) since June 24, 2024, has intimated the closure of its Trading Window from April 1, 2026, until 48 hours after the RP Committee Meeting approving audited standalone and consolidated financial results for the fourth quarter and year ending March 31, 2026. This applies to all suspended Board of Directors and Designated Employees per the Company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2018. During CIRP, board and committee roles under SEBI (LODR) Regulations are fulfilled by Resolution Professional Ashish Vyas.

• ·CIRP commenced pursuant to NCLT Mumbai Bench - VI order no. CP (IB) No. 250/MB/2022 dated June 24, 2024 (received by IRP on June 25, 2024).
• ·First Committee of Creditors meeting on July 24, 2024; e-voting for RP appointment concluded September 14, 2024.
• ·NSE Symbol: SHIRPUR-G; BSE Scrip Code: 512289.
• ·Company CIN: L51900MH1984PLC034501; Registered office: Refinery Site Shirpur, Dist. Dhule, Dhulia, Maharashtra, India, 425405.

27-03-2026

Setubandhan Infrastructure Limited, undergoing CIRP since admission by NCLT Mumbai on 28 November 2022 with Sandeep D. Maheshwari as Resolution Professional, had its CoC-approved resolution plan rejected by NCLT on 24 March 2025, with an appeal pending before NCLAT since 09 July 2025. The trading window for dealing in company securities is closed for designated persons from 01 April 2026 until 48 hours after the RP Committee Meeting approving audited financial results for Q4 and FY ending 31 March 2026. This development underscores ongoing insolvency challenges with no resolution in sight.

• ·CIRP application filed by State Bank of India under Section 7 of IBC 2016.
• ·Interim RP appointed 28 November 2022, confirmed by CoC on 28 December 2022.
• ·NSE Symbol: SETUINFRA; BSE Scrip Code: 533605.
• ·RP email: setu.cirp@gmail.com; AFA valid up to 31 December 2026.

27-03-2026

Refex Industries Limited filed a Company Application on March 26, 2026, before the Hon’ble National Company Law Tribunal (NCLT), Chennai Bench, seeking directions for the proposed Composite Scheme of Amalgamation and Arrangement involving Refex Green Mobility Limited (Transferor Company), Refex Industries Limited (Transferee/Demerged Company), and Refex Mobility Limited (Resulting Company). This follows earlier intimations dated September 22, 2025, and March 17, 2026, under Sections 230-232 of the Companies Act, 2013. The disclosure complies with Regulation 30 of SEBI Listing Regulations.

• ·Application filed before NCLT Chennai Bench
• ·Security Code: 532884; Symbol: REFEX
• ·Disclosure dated March 27, 2026

27-03-2026

India Finsec Limited's Board approved initiating the IPO process for subsidiary IFL Finance Limited (formerly IFL Housing Finance Limited), involving up to 3,60,00,000 equity shares via fresh issue and up to 40,00,000 via offer for sale, subject to shareholder and regulatory approvals. The Board also approved an EGM notice with remote e-voting from April 21, 2026 (9:00 a.m.) to April 23, 2026 (5:00 p.m.), cut-off date April 17, 2026, and appointed M/s Sarita Singh & Associates as scrutinizer. Additionally, Mr. Devi Dass Agarwal was re-appointed as Independent Director for five years from July 1, 2026 to June 30, 2031, pending shareholder approval.

• ·Board meeting held on March 27, 2026, from 1:30 P.M. to 2:00 P.M.
• ·Scrutinizer: M/s Sarita Singh & Associates (C.P. No: 24682).
• ·Mr. Devi Dass Agarwal has 43 years of experience in banking and finance, including 18 years as Branch Head at Central Bank of India; not related to any directors and not debarred.

27-03-2026

Halder Venture Limited paid a Standard Operating Procedure (SOP) fine of ₹5,42,800 (including GST) to BSE on March 26, 2026, for non-compliance with Regulation 17(1) of SEBI (LODR) Regulations, 2015, related to the composition of its Board of Directors for the quarter ended September 2025. This follows the rejection of a waiver application, as previously disclosed on March 19, 2026. The company reported no material impact on financial, operational, or other activities beyond the fine amount.

• ·Order received via email on March 18, 2026 at 4:41 PM.
• ·Payment details: UTR No. INF/INFT/774529182646/BSER11070 via ICICI Bank RTGS/NEFT.
• ·Disclosure in continuation of earlier notice dated March 19, 2026 regarding rejection of waiver application.

27-03-2026

On March 24, 2026, William P. Rowland resigned from the Board of Directors, including all committees, and as Interim Chief Financial Officer of One World Products, Inc., citing ongoing health issues with no disagreements on operations, policies, or practices. Isiah L. Thomas, III, the Company's CEO, has assumed the CFO duties on an interim basis until a successor is appointed. The 8-K was filed on March 27, 2026, including the resignation letter as Exhibit 17.1.

• ·Resignation effective March 24, 2026 (earliest event reported).
• ·Company address: 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, Nevada 89149.
• ·Commission file number: 000-56151; I.R.S. Employer Identification No.: 61-1744826.

27-03-2026

Cyber Enviro-Tech, Inc. (CETI) entered into an Equity Purchase Agreement with Monroe Street Capital Partners, LP on March 20, 2026, providing the right to sell up to $30,000,000 of common stock over a 24-month Commitment Period, subject to conditions including put notices with minimum $25,000 and maximum $500,000 per put. As consideration, CETI issued 3,000,000 Initial Commitment Shares immediately and agreed to issue additional 3,000,000 Fulfillment Commitment Shares upon each of the first three $2,500,000 gross proceeds milestones. Concurrently, a Registration Rights Agreement requires filing a resale registration statement within 30 days and maintaining its effectiveness.

• ·Commitment Period: 24 months from March 20, 2026, or earlier termination events.
• ·Registration Statement filing deadline: within 30 calendar days after March 20, 2026.
• ·Registration effectiveness target: within 90 calendar days after filing.
• ·Common Stock trading symbol: CETI on OTCQB.
• ·Principal Executive Offices: 6991 E. Camelback Road, Suite D-300, Scottsdale, Arizona 85251.

27-03-2026

BHAV Acquisition Corp, a blank check company, consummated its IPO on March 20, 2026, selling 10,000,000 units at $10.00 per unit, generating $100,000,000 in gross proceeds. Simultaneously, it completed a private placement of 200,000 units at $10.00 per unit to its sponsor BHAV Partners LLC and others, yielding $2,000,000. A total of $100,000,000 was placed in a trust account at $10.00 per unit for public shareholders.

• ·Total assets as of March 20, 2026: $101,085,982
• ·Total current liabilities: $223,281 (including $114,381 accrued offering costs and $93,900 over-allotment option liability)
• ·Shareholders' equity: $862,701 (with accumulated deficit of $113,753)
• ·Company focuses on business combinations in advanced robotics, EVs, drones, UAS, or fintech sectors
• ·Sponsor purchased 135,000 private units; at-risk capital investors purchased 65,000

27-03-2026

Trilogy Metals Inc. has filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Shareholders on May 13, 2026, at 10:00 a.m. Vancouver time, where shareholders will receive the audited consolidated financial statements for the fiscal year ended November 30, 2025, elect directors, appoint auditors, and vote on a non-binding advisory resolution approving Named Executive Officer compensation. The record date is March 20, 2026, with 172,545,639 Common Shares outstanding, entitling holders to one vote per share. Proxies must be received by May 11, 2026, at 10:00 a.m. Vancouver time.

• ·Quorum at the Meeting requires two or more persons representing at least 5% of Common Shares entitled to vote.
• ·Proxy submission options include delivery to Computershare Toronto office, fax (416-263-9524 or 1-866-249-7775), telephone (1-866-732-8683 or (312) 588-4290), or internet.
• ·Meeting materials available on company website (www.trilogymetals.com), SEDAR+ (www.sedarplus.ca), and EDGAR (www.sec.gov).

27-03-2026

Nurix Therapeutics' proxy statement features a CEO letter highlighting 2025 clinical advancements, including bexobrutideg's 83.0% ORR, 22.1-month median PFS, and 20.1-month median DOR in heavily pretreated CLL patients from Phase 1a/1b trials, with pivotal DAYBreak-201 Phase 2 and planned DAYBreak-306 Phase 3 studies underway. The company ended FY2025 with $592.9 million in cash, cash equivalents, and marketable securities after a $250.0 million offering, recognized $84.0 million in collaboration revenue from partners like Gilead, Sanofi, and Pfizer, and remains eligible for up to $6.1 billion in future milestones plus royalties. 2026 priorities focus on advancing bexobrutideg to Phase 3 in oncology, expanding into I&I indications, and progressing partnered programs like STAT6 and IRAK4 degraders.

• ·Annual Meeting scheduled for May 15, 2026 at 9:00 a.m. PT via virtual webcast at www.virtualshareholdermeeting.com/NRIX2026
• ·Stockholders of record as of March 20, 2026 entitled to vote
• ·Agenda: Elect three Class III directors for three-year terms; Ratify PricewaterhouseCoopers LLP as independent auditors for FY ending November 30, 2026; Advisory approval of named executive officer compensation

27-03-2026

Murphy Oil Corporation's 2026 Proxy Statement highlights strong 2025 operational performance, including average production of 182 MBOEPD (up from 177 MBOEPD in 2024), a 20% year-over-year reduction in LOE/BOE to $10.89, 103% reserve replacement with 715 MMBOE proved reserves, and $1.2B in cash from continuing operations, of which $301.3M was free cash flow with $286M returned to shareholders. Key successes included multiple oil discoveries in Vietnam and the U.S. Gulf of America, alongside financial strengthening via RCF upsizing to $2.00B and $500M notes issuance. However, production growth was modest at approximately 3% YoY, and two of three exploration wells in Côte d’Ivoire delivered non-commercial results.

• ·U.S. Gulf of America offshore production: 63 MBOEPD in 2025
• ·Canada offshore production: 7 MBOEPD in 2025
• ·Vietnam Hai Su Vang resource potential: toward higher end of 170 to 430 MMBOE range
• ·Acquired 14 blocks in Gulf of America lease sale in December 2025
• ·Lac Da Vang first oil on track for Q4 2026
• ·Two non-commercial wells in Côte d’Ivoire three-well exploration program
• ·Annual meeting scheduled for May 13, 2026

27-03-2026

Sportradar Group AG reported strong revenue growth of 17% YoY to €1,290M in 2025 from €1,107M in 2024, with Adjusted EBITDA rising 33% to €297M and profit from continuing operations surging to €100M (7.8% margin) from €34M (3.0% margin). However, Customer Net Retention Rate declined to 109% from 127% YoY, signaling potential customer retention challenges, while significant indebtedness requires dedicating material cash flow to debt payments.

• ·Non-routine litigation costs increased to €35,156k in 2025 from €3,381k in 2024.
• ·Restructuring costs €6,676k in 2025.
• ·Transaction-related costs €11,636k and secondary offering costs €2,191k in 2025.
• ·Significant foreign currency gains of €78,814k in 2025 vs losses of €38,223k in 2024.
• ·Finance costs rose to €86,531k in 2025 from €78,870k in 2024.

27-03-2026

Bed Bath & Beyond's 2026 Proxy Statement outlines Proposal 1 for the election of seven director nominees at the annual meeting: Marcus A. Lemonis (Chairman since 2023, Executive Chairman since 2024, CEO since January 1, 2026), Joanna C. Burkey, Barclay F. Corbus, William B. Nettles, Jr., Debra G. Perelman, Dr. Robert J. Shapiro, and Joseph J. Tabacco, Jr., each to serve until the 2027 annual meeting. The company will engage Georgeson LLC for proxy solicitation services at an anticipated cost of $16,500 plus reimbursements. Proxy materials and the 2025 Form 10-K are available online at investors.beyond.com or by request to Investor Relations.

• ·Proxy solicitation costs borne by the company, with reimbursements to brokers and use of officers/directors/employees without additional compensation.
• ·Investor Relations contact: ir@beyond.com or Bed Bath & Beyond, Inc., Attention: Investor Relations, 433 Ascension Way, 3rd Floor, Murray, Utah 84123.
• ·Proxy solicitor contact: Georgeson LLC at (866) 510-7490.
• ·Meeting results to be reported in Form 8-K within four business days.

27-03-2026

Southwest Airlines Co's 2026 DEF 14A Proxy Statement discloses XBRL-tagged executive compensation data for Principal Executive Officers (PEOs) Robert E. Jordan and Gary C. Kelly across 2021-2025, including equity awards, fair value changes, and adjustments for PEO and Non-PEO NEOs. The filing confirms 491,075,748 shares of common stock outstanding as of the March 11, 2026 record date and outlines insider trading policies prohibiting hedging, short sales, pledging, and margin accounts. It also begins disclosure of security ownership for 5%+ beneficial owners as of February 28, 2026.

• ·Company’s Insider Trading Policy prohibits hedging, monetization transactions, short sales, and derivatives involving Company securities for Directors, officers, Employees, consultants, designees, spouses, and household members.
• ·Directors and officers prohibited from holding Company securities in margin accounts or pledging as collateral for loans.
• ·Disclosure of Security Ownership of Certain Beneficial Owners (more than 5% of common stock) as of February 28, 2026.

27-03-2026

Indivior delivered solid 2025 financial results with total net revenue up 4% YoY to $1.24 billion, driven by U.S. SUBLOCADE net revenue growth of 13% to a record $856 million. GAAP net income increased 30x to $210 million from 2024, and Adjusted EBITDA rose 20% YoY to $428 million with a 500 bps margin expansion to 35%. The company completed Phase I of the Indivior Action Agenda, strengthened its balance sheet with 0.7x net leverage, resolved the legacy DOJ matter, and authorized a $400 million share repurchase program, positioning for Phase II acceleration in 2026 ahead of the May 13, 2026 Annual Meeting.

• ·Annual Meeting: May 13, 2026 at 10:00 a.m. ET (virtual at www.virtualshareholdermeeting.com/INDV2026)
• ·Record Date: March 18, 2026
• ·Proposals: Elect 8 directors; Advisory vote on say-on-pay; Advisory vote on say-on-frequency (1 year); Ratify PwC as auditor for FY ending Dec 31, 2026
• ·Net leverage: 0.7x at year-end 2025
• ·Resolved legacy DOJ matter

27-03-2026

KKR Enhanced US Direct Lending Fund-L Inc., as Collateral Manager, and KKR Enhanced US EVDL Funding LLC, as Borrower, entered into Amendment No. 2 to the Loan and Servicing Agreement dated March 23, 2026, amending the original April 1, 2024 agreement with Citibank, N.A. as Administrative Agent and The Bank of New York Mellon Trust Company, National Association as Collateral Agent. The amendment updates the conformed Loan and Servicing Agreement to provide a secured revolving credit facility of up to U.S.$1,250,000,000 for financing Eligible Collateral Assets. No Events of Default were reported, and all representations and warranties remain true and correct post-amendment.

• ·Amendment effective upon execution, delivery of good standing certificate, board resolutions, and legal opinion from Dechert LLP.
• ·Original Loan and Servicing Agreement dated April 1, 2024.
• ·Governed by New York law.

27-03-2026

Cartesian Growth Corporation III (CGC), a SPAC, entered into an Amendment to its Business Combination Agreement dated December 17, 2025, with Merger Sub (Fenway MS, Inc.) and Factorial Inc., effective March 26, 2026. The amendments adjust the timing of CGC Shareholder Redemption to occur at least one day prior to Domestication, update definitions including Ancillary Documents, Company Convertible Notes, Required Transaction Proposals, and Nasdaq Proposals, add pre-Domestication actions, and reserve Sections 5.21 and 5.22. No financial terms or impacts are disclosed in the amendment.

• ·Original Business Combination Agreement dated December 17, 2025
• ·Amendment governed by New York law with exclusive jurisdiction in New York courts
• ·Includes updates to Preamble paragraphs regarding Shareholder Redemption and Registration Rights Agreement

27-03-2026

On March 26, 2026, Traeger, Inc.'s Board of Directors reviewed the 2025 annual cash incentive program and determined that performance goals were not achieved, resulting in no payments to the company's named executive officers. Despite this, the Board awarded discretionary cash bonuses of $956,250 to CEO Jeremy Andrus and $270,938 to CFO Michael Joseph (Joey) Hord for their 2025 contributions and to promote retention. No departures, elections, or appointments of directors or officers were reported.

• ·Event reported on Form 8-K filed March 27, 2026, under Item 5.02 for Compensatory Arrangements of Certain Officers

27-03-2026

On March 22, 2026, Totaligent, Inc. entered into an Extension Amendment to its Binding Letter of Intent dated February 22, 2026, with GloMed Solutions Limited Liability Company, extending the target dates for negotiating definitive agreements (including joint venture and IP assignment agreements) and closing the proposed transaction to April 22, 2026. The binding exclusivity period under the LOI is also extended through April 22, 2026. All other terms of the LOI, which outlines a joint venture formation and a call option for Totaligent to acquire GloMed's business, operations, IP, and assets, remain unchanged.

• ·Original LOI disclosed in 8-K filed February 23, 2026
• ·Extension Amendment filed as Exhibit 10.1